Scott Bizily
Chief Legal Officer · 3 filings · Latest: Jun 30, 2026
4D Molecular Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
FDMT | Scott Bizily | Chief Legal Officer | Jun 30, 2026 | Sale | $14.00 | 6,566 | $91.9K | 8,617 | |
FDMT | Scott Bizily | Chief Legal Officer | Jun 30, 2026 | Option Exercise | $6.20 | 6,566 | $40.7K | 15,183 | |
FDMT | SCOTT BIZILY | — | Jun 30, 2026 | Proposed Sale | $12.88 | 6,566 | $84.6K | — | |
FDMT | Scott Bizily | Chief Legal Officer | Jun 23, 2026 | Sale | $12.00 | 9,810 | $117.7K | 8,617 | |
FDMT | Scott Bizily | Chief Legal Officer | Jun 23, 2026 | Option Exercise | $4.14 | 9,810 | $40.6K | 18,427 | |
FDMT | SCOTT BIZILY | — | Jun 23, 2026 | Proposed Sale | $10.42 | 9,810 | $102.2K | — | |
FDMT | SCOTT BIZILY | — | Dec 16, 2025 | Proposed Sale | $10.95 | 1,635 | $17.9K | — | |
FDMT | SCOTT BIZILY | — | Nov 17, 2025 | Proposed Sale | $10.79 | 1,635 | $17.6K | — | |
FDMT | SCOTT BIZILY | — | Oct 24, 2025 | Proposed Sale | $10.00 | 1,816 | $18.2K | — | |
FDMT | SCOTT BIZILY | — | Sep 23, 2025 | Proposed Sale | $7.40 | 7,312 | $54.1K | — |